Genotype frequencies in patients with EBV+ HL and control participants
| Genotype . | EBV+ HL, no. % . | Control participants, no. % . | P, EBV+ HL versus control* . |
|---|---|---|---|
| n | 70 | 59 | — |
| HLA-A*01/*01 | 18.6 (13) | 1.7 (1) | < .001 |
| HLA-A*02/*02 | 1.4 (1) | 20.3 (12) | < .001 |
| HLA-A*01/*02 | 5.7 (4) | 8.5 (5) | .73 |
| HLA-A*01/*X | 31.4 (22) | 18.6 (11) | .097 |
| HLA-A*02/*X | 21.4 (15) | 35.6 (21) | .074 |
| HLA-A*X/*X | 21.4 (15) | 12.9 (9) | .37 |
| Genotype . | EBV+ HL, no. % . | Control participants, no. % . | P, EBV+ HL versus control* . |
|---|---|---|---|
| n | 70 | 59 | — |
| HLA-A*01/*01 | 18.6 (13) | 1.7 (1) | < .001 |
| HLA-A*02/*02 | 1.4 (1) | 20.3 (12) | < .001 |
| HLA-A*01/*02 | 5.7 (4) | 8.5 (5) | .73 |
| HLA-A*01/*X | 31.4 (22) | 18.6 (11) | .097 |
| HLA-A*02/*X | 21.4 (15) | 35.6 (21) | .074 |
| HLA-A*X/*X | 21.4 (15) | 12.9 (9) | .37 |
X indicates an allele other than *01 and *02; —, not applicable.
Compared with all other genotypes.